Related Experiment Videos
Crystallization and atomic resolution X-ray diffraction analysis of antichymotrypsin variants
Biochemical and Biophysical Research Communications
|October 29, 1993
Summary
Researchers crystallized two recombinant antichymotrypsin (rACT) variants, achieving 2.5 A resolution. This breakthrough provides the best diffraction data yet for crystalline, inhibitory serpins, advancing structural biology.
Area of Science:
- Biochemistry
- Structural Biology
- Crystallography
Background:
- Recombinant antichymotrypsin (rACT) is a key serpin with important physiological roles.
- Previous crystallization efforts for inhibitory serpins have faced resolution limitations.
- Understanding the structure of rACT variants is crucial for elucidating their function.
Purpose of the Study:
- To prepare and characterize crystals of two novel recombinant antichymotrypsin (rACT) variants.
- To achieve high-resolution diffraction data for these rACT variants.
- To investigate structural features contributing to crystal quality.
Main Methods:
- Crystallization of two recombinant antichymotrypsin (rACT) variants: rACT-T345R and ACT'.
- X-ray diffraction analysis to determine crystal space groups and unit cell parameters.
- Assessment of diffraction resolution limits.
Main Results:
- Crystals of rACT-T345R were obtained in space group P2(1).
- Crystals of ACT' were obtained in space group P2(1)22(1).
- Both variants diffracted to a limiting resolution of 2.5 A, the best achieved for inhibitory serpins.
Conclusions:
- High-quality crystals of rACT variants have been successfully prepared.
- The achieved resolution advances the structural understanding of inhibitory serpins.
- Engineered features, including disulfide crosslinking and inter-monomer interactions, likely contribute to the exceptional crystal quality of ACT'.